SN-38 is inactivated by the enzyme UGT1A1 by glucuronidation, so that patients with UGT1A1 polymorphism are likely to develop severe irinotecan-related toxicities such as diarrhea and neutropenia [21]. Here, UGT1A1 is linked to neutropenia.